MENU
ARTL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Artelo Biosciences (ARTL) Earnings Date & Reports

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

ARTL is expected to report earnings to fall 88.89% to -12 cents per share on May 08

Artelo Biosciences ARTL Stock Earnings Reports
Q1'25
Est.
$-0.13
Q4'24
Missed
by $0.73
Q3'24
Beat
by $0.44
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.13
The last earnings report on March 03 showed earnings per share of -116 cents, missing the estimate of -43 cents. With 47.51K shares outstanding, the current market capitalization sits at 3.01M.
View a ticker or compare two or three
ARTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
505 Lomas Santa Fe
Phone
+1 858 925-7049
Employees
6
Web
https://www.artelobio.com